Cite
HARVARD Citation
Niavarani, S. et al. (2020). Oncolytic vesicular stomatitis virus–based cellular vaccine improves triple-negative breast cancer outcome by enhancing natural killer and CD8+ T-cell functionality. Journal for immunotherapy of cancer. 8 (1), p. . [Online].